Bellerophon Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.06 |
Market Cap |
$43.14 M |
Shares Outstanding |
68.91 M |
Public Float |
50.21 M |
Address |
184 Liberty Corner Road Warren New Jersey 07059 United States |
Employees | - |
Website | http://www.bellerophon.com |
Updated | 07/08/2019 |
Bellerophon Therapeutics, Inc clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. |